Vidcast:  https://youtu.be/r2Op7LBY5h8

 

An international collaborative research group has demonstrated that a commercially-available breathalyzer, the TERA.Bio system, can diagnose CoVid.  It does so by detecting the spectral signature of CoVid19-specifiic volatile organic compounds in the exhaled breaths of the infected.  

 

Testing a group of 70 CoVid-infected and 700 uninfected persons, the breathalyzer test  achieved 92.6% sensitivity and 96% specificity when compared with the gold standard PCR test.  Additional studies are continuing to study the validity and usefulness of the test for screening the asymptomatic.  Stay tuned.

 

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0273506

 

#CoVid #breathalyzer #diagnosis #vocs #pcr